Cargando…
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer
Endocrine therapy has successfully been used to treat estrogen receptor (ER)-positive breast cancer, but this invariably fails with cancers becoming refractory to treatment. Emerging evidence has suggested that fluctuations in ER co-regulatory protein expression may facilitate resistance to therapy...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288188/ https://www.ncbi.nlm.nih.gov/pubmed/25488809 http://dx.doi.org/10.1093/nar/gku1298 |